Extracellular hemoglobin (Hb) has multiple biological activities that can initiate and exacerbate disease processes.^[@bib1]^ In acquired and genetic hemolytic anemias, malaria, massive blood transfusions, and severe infections, the presence of free Hb appears to cause endothelial dysfunction, vascular damage, and inflammation.^[@bib2]^ More-localized effects of extracellular Hb are relevant during the initiation and propagation of atherosclerosis and in the regulation of inflammation and wound healing.^[@bib3],\ [@bib4]^

During mild hemolysis, Hb and heme scavenger plasma proteins attenuate the adverse effects of extracellular Hb.^[@bib1]^ Haptoglobin (Hp) binds extracellular Hb to form an irreversible complex that can be cleared by CD163-positive monocytes and macrophages.^[@bib5],\ [@bib6],\ [@bib7]^ Preclinical studies have suggested a strong therapeutic potential for Hp infusion in conditions with enhanced intravascular hemolysis.^[@bib8],\ [@bib9]^ Within the Hb/Hp complex, the inherent vasoactivity of free Hb remains controlled, its redox reactivity is stabilized, and Hb itself is protected against oxidative damage.^[@bib8],\ [@bib10],\ [@bib11]^

On a molecular level, the pathophysiology of Hb is generally explained by its side reactions.^[@bib1]^ Among these reactions, depletion of the vasodilator nitric oxide (NO) and its reaction with hydrogen peroxide (H~2~O~2~) are the most extensively studied. H~2~O~2~ is produced by nicotinamide adenine dinucleotide phosphate oxidases at supra-physiological levels upon tissue damage by resident tissue cells (i.e., epithelial cells) and during the subsequent inflammatory reaction by invading leukocytes.^[@bib12],\ [@bib13],\ [@bib14]^ However, although NO depletion and associated endothelial dysfunction is now an accepted pathophysiologic model, a set of cohesive mechanistic concepts that link the oxidative side reactions of Hb to adverse cellular and physiologic responses is still lacking. Specifically, gaps in our knowledge remain concerning the mechanisms that link the primary biochemical processes (i.e., the reactions of Hb with H~2~O~2~) with the reaction intermediates, final effectors, and pathways that ultimately determine cellular- and tissue-level damage. Accordingly, the mechanisms by which Hp could protect against oxidative Hb toxicity are not clear. The current theories causally relate oxidative Hb toxicity and Hp protection to diverse mechanisms even in the absence of strong biological evidence.^[@bib11],\ [@bib15],\ [@bib16],\ [@bib17],\ [@bib18],\ [@bib19],\ [@bib20]^

In this study, we utilized a systematic approach to characterize Hp-attenuated reaction species that could mediate 'oxidative\' toxicity of Hb to endothelial cells. The toxic species identified include primary globin denaturation products and secondary lipoprotein peroxidation products, both of which result from the continuous reactions of Hb with physiological levels of H~2~O~2~.

Our results suggest that the anti-oxidative function of Hp against endothelium-directed Hb toxicity is based primarily on two activities. First, Hp stabilizes the protein structure of Hb itself, thus preventing unfolding and aggregation of the protein, and second, Hp halts heme and/or radical transfer from Hb to reactive lipoproteins. Importantly, this caging effect of Hp allows the Hb/Hp complex to function as a protective sink for reactive oxygen species within Hb- and H~2~O~2~-exposed tissues.

Results
=======

Hb degradation products are an Hp-attenuated mediator of endothelial damage
---------------------------------------------------------------------------

We incubated human endothelial cells with human Hb (Fe^2+^, 2 mg/ml) and a low level of the H~2~O~2~-generating enzyme glucose oxidase (GOX; 2.5 mU/ml) to simulate the conditions of concurrent extracellular Hb exposure and oxidative stress ([Figure 1](#fig1){ref-type="fig"}). Low activities of GOX in cell culture medium have been found to mimic levels of H~2~O~2~ produced by stimulated neutrophil granulocytes.^[@bib14]^ Electrical endothelial resistance was measured as a functional surrogate marker of endothelial damage. Combined treatment with human Hb and GOX resulted in a rapid decrease in endothelial resistance that occurred within hours of the onset of the incubation period. [Figure 1a](#fig1){ref-type="fig"} shows representative experiments for human umbilical vein endothelial cells (HUVECs) and human pulmonary artery endothelial cells (HPAECs); comparable results were obtained with human lung microvascular endothelial cells (HLMVECs) and human lymphatic endothelial cells (HLyECs) in preliminary studies (data not shown). This decrease in endothelial electrical resistance was accompanied by the redistribution of the adherens junction protein *β*-catenin and ultrastructural evidence of intercellular gap formation in regions with decreased *β*-catenin staining ([Figure 1b](#fig1){ref-type="fig"}). In contrast, when applied alone, even prolonged incubations with either human Hb or GOX did not induce any measurable changes in cell function or morphology. The GOX activity used in these studies has been shown to generate steady-state H~2~O~2~ levels in the range of 5--20 *μ*M in cell culture, which is in a low supra-physiologic range observed acutely after wounding.^[@bib12],\ [@bib21],\ [@bib22]^ Gene array analysis confirmed that the low level of H~2~O~2~ generated in this model induced only minimal changes in overall gene expression that were not indicative of oxidative stress or cell damage ([Supplementary Figure 1](#sup1){ref-type="supplementary-material"}).

The human Hb+GOX-induced damage in HPAEC ([Figure 1c](#fig1){ref-type="fig"}) was completely prevented by the addition of purified human Hp (2 mg/ml). Identical protection was also found for other endothelial cell types (HPAEC, HLMVEC, and HLyEC; data not shown).

Our earlier studies suggested that Hb bound to Hp in the Hb/Hp complex can still react with H~2~O~2~, but the structure of the Hb/Hp complex remains protected from oxidative damage and denaturation.^[@bib23]^ In contrast, in the absence of Hp, free Hb is extensively oxidized at specific amino-acid sites leading to structural destabilization of the protein with subsequent denaturation, covalent protein cross-linking, and aggregation.^[@bib24],\ [@bib25],\ [@bib26]^ Therefore, we speculated that the toxicity that occurs in our model in the absence of Hp may be induced by such Hb denaturation and aggregation products. To test this hypothesis, we probed our cell culture system with two types of Hb that are more resistant to oxidative protein degradation by H~2~O~2~. These proteins were (1) *α*-*α*-cross-linked human Hb (*α*XLHb). This Hb is a tetrameric Hb, which is stabilized by the chemical cross-linker bis(3,5-dibromosalicyl)fumarate (DBBF), and (2) bovine Hb (bvHb), which is a dissociable tetramer with an enhanced conformational stability because of its specific amino-acid sequence. Aggregation that could occur upon unfolding of the different Hbs as well as of the Hb/Hp complex during H~2~O~2~ reactions can be monitored by spectrophotometry. As shown in [Figure 2a](#fig2){ref-type="fig"}, aggregate formation can be observed with native human Hb but not with *α*XLHb, bvHb, or the Hb/Hp complex. In strong correlation with the absent aggregate formation, the oxidation of the structurally stabilized Hbs was not associated with endothelial damage ([Figure 2b](#fig2){ref-type="fig"}). The generation of Hb denaturation products with the unstable human Hb could also be observed in cell culture by scanning electron microscopy (SEM; [Figure 2c](#fig2){ref-type="fig"}). We found extensive aggregate endothelial cell interactions with engulfment of the nanometer- to micrometer-sized particles by HPAECs ([Figure 2d](#fig2){ref-type="fig"}). Therefore, we assumed that one mechanism of oxidative Hb toxicity is directly related to the appearance of these Hb denaturation/aggregation products that have the ability to initiate endothelial cell damage (mechanism 1 in Figure 7).

The intrinsic Hb oxidation pathway generates toxic reaction products that are attenuated by Hp
----------------------------------------------------------------------------------------------

To conclusively dissect the biological impact of the different Hb oxidation products, we biochemically characterized the H~2~O~2~ reactions of all evaluated types of Hb and correlated the generation of different oxidation products with the observed biological responses of endothelial cells. Under identical conditions as in our cell culture experiments (i.e., 37 °C and complete endothelial cell culture medium), Hb heme-iron oxidation with production of HbFe^3+^ and HbFe^4+^ was similar for human Hb, *α*XLHb, bvHb, and the Hb/Hp complex ([Figure 3a](#fig3){ref-type="fig"}). Heme release was slightly reduced with bvHb and *α*XLHb, but only the Hb/Hp complex completely prevented heme transfer from ferric Hb to hemopexin (Hpx; [Figures 3b and c](#fig3){ref-type="fig"}). EPR-detectable 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline-*N*-oxide (DEPMPO) radicals were highest with the Hb/Hp complex, which is compatible with a radical-stabilizing function of Hp.^[@bib11]^ Human Hb, *α*XLHb, and bvHb all led to similar levels of free radical production ([Figure 3d](#fig3){ref-type="fig"}).

In this first model, it is likely that the Hb degradation products, which are unique for the H~2~O~2~ reaction with the human Hb, are the toxic species. Generation of the primary heme-iron oxidation products (Hb-Fe^3+^ and Hb-Fe^4+^), DEPMPO-trappable radicals, and free heme are common among all reactions that occurred in the toxic as well as in the nontoxic conditions. These species could therefore be excluded as the ultimate mediators of toxicity.

The extrinsic Hb oxidation pathway generates toxic lipid oxidation products in the absence of Hp
------------------------------------------------------------------------------------------------

To evaluate the role of Hb reactions with extrinsic (non-Hb) molecules, we supplemented our cell culture model by adding human plasma-derived low-density lipoprotein (LDL) as a potential substrate of Hb\'s peroxidative activity. The addition of 0.5 mg/ml LDL to the Hb-H~2~O~2~ reaction led to a cytotoxic endothelial response with loss of electric monolayer resistance ([Figures 4b and c](#fig4){ref-type="fig"}). This endothelial damage mechanism was independent of Hb\'s intrinsic structural stability and did occur with human Hb, bvHb ([Figure 4b](#fig4){ref-type="fig"}), and *α*XLHb ([Figure 4c](#fig4){ref-type="fig"}). No changes in electrical resistance and/or morphology were observed during incubation of endothelial cells with LDL±GOX in the absence of Hb. The Hb/Hp complex attenuated Hb-driven LDL peroxidation and, accordingly, Hp significantly delayed the endothelial monolayer damage that was associated with Hb-driven LDL oxidation ([Figure 4c](#fig4){ref-type="fig"}; mechanism 2 in [Figure 7](#fig7){ref-type="fig"}).

Inflammation *versus* cytotoxicity. Intrinsic and extrinsic oxidative Hb reaction pathways trigger distinct endothelial damage
------------------------------------------------------------------------------------------------------------------------------

Based on the presented experiments, two principal oxidative Hb reaction pathways can be discriminated. An intrinsic oxidation pathway generates Hb degradation products, whereas an extrinsic oxidation pathway generates secondary lipid oxidation products. Both of them can eventually lead to endothelial damage and both are attenuated by Hp ([Figure 7](#fig7){ref-type="fig"}). Further evidence for the discriminative nature of these two mechanisms could be provided if unique cellular responses could be defined that are specifically triggered by these two reactions. Therefore, we characterized the messenger ribonucleic acid (mRNA) expression profile of HPAECs in response to the two toxic reactions by gene array analysis ([Figure 5](#fig5){ref-type="fig"}).

[Figure 5a](#fig5){ref-type="fig"} summarizes the reaction products that are generated during the different toxic and nontoxic incubation conditions and which eventually could stimulate transcriptional responses in endothelial cells. [Figure 5b](#fig5){ref-type="fig"} shows a principal component analysis (PCA) of the global mRNA transcriptome changes triggered by the different treatments. The PCA shows that the individual experimental samples cluster within three distinct groups. Within the first group (multiple colors) we find the control samples, as well as the samples that were exposed to the previously defined nontoxic Hb reactions. Specifically, within this group we identified the samples that were only treated with Hb (Fe^2+^) as well as the samples treated with the structurally stable bvHb+GOX where redox cycling (Fe^3+^/Fe^4+^ formation) as well as heme release and radical production (but not globin degradation or LDL oxidation) do occur. These data confirm that in this model radical generation, ferric and ferryl Hb formation and heme release are not the immediate inducers of the adverse endothelial response. In contrast, the transcriptome profile of the samples treated with the unstable human Hb+GOX (green) and samples exposed to bvHb+LDL+GOX (brown) clearly separated from each other and from all other conditions.

To extract meaningful gene signatures that may better define the apparently dichotomous adverse cellular responses, we have selected all genes that were differently expressed in any of the five tested conditions. The level of selection stringency was set at greater than twofold upregulation compared with control cells at FDR 0.05 (ANOVA). The 2046 genes that met these inclusion criteria served as an input data set for the hierarchical two-way clustering analysis shown in [Figure 5c](#fig5){ref-type="fig"}. As expected from the PCA, the samples treated with 'nontoxic\' conditions do not separate from each other and it is not reasonable to extract characteristic gene clusters or expression patterns for any of these treatments, underpinning the minimal impact of the 'common\' Hb reaction products on the endothelium. However, the samples treated with bvHb+LDL+GOX and those treated with human Hb+GOX clustered in two distinct groups were clearly discriminated from each other by non-overlapping gene signatures (see also [Supplementary Excel Table](#sup1){ref-type="supplementary-material"} for more detailed data).

A functional analysis of the exposure-specific gene clusters was performed with a comparative Metacore (Thomson Reuters, New York, NY, USA) network analysis. The top 10 significantly enriched functional networks for each condition are shown in [Figure 5d](#fig5){ref-type="fig"}. The response of cells treated with bvHb+LDL+GOX (gene cluster A) is characterized by upregulation of heat shock proteins (e.g., heat shock protein 70) and activating transcription factor 3 (ATF3), which is a known stress-inducible transcription factor.^[@bib27]^ In contrast, the human Hb aggregates evoke a paramount inflammatory response with the adhesion molecule E-Selectin (SELE) as the most upregulated signature gene (gene cluster B; see also [Supplementary Excel Table](#sup1){ref-type="supplementary-material"} and [Supplementary Figure 3](#sup1){ref-type="supplementary-material"} for more detailed data).

The apparent dichotomy of the cellular responses to the Hb aggregates and the oxidized LDL, respectively, can also be illustrated by a morphological analysis of adherence junction (*β*-catenin) and cytoskeleton (actin) morphology ([Supplementary Figure 2](#sup1){ref-type="supplementary-material"}).

The shielded pseudoperoxidase activity of Hb within the Hb/Hp complex can protect endothelial cells against peroxidative damage
-------------------------------------------------------------------------------------------------------------------------------

Formation of the Hb/Hp complex does not change the pseudoperoxidase (H~2~O~2~-consuming) activity of Hb. Therefore, as an ultimate effect, Hp protection could imply that this pseudoperoxidase activity could represent a novel antioxidant function of the complex.^[@bib23],\ [@bib26],\ [@bib28]^ To test this hypothesis, we adjusted our cell culture system to mimic conditions of toxic H~2~O~2~ exposure ([Figure 6](#fig6){ref-type="fig"}). The amount of H~2~O~2~ generated *in situ* by 20 mU/ml GOX (high GOX) is estimated to produce H~2~O~2~ steady-state levels in high supra-physiologic range (50--100 *μ*M) and induced endothelial cell damage.^[@bib21]^ Specifically, redistribution/disappearance of the adherens junction protein *β*-catenin and a decrease in transendothelial resistance could be observed within hours ([Figures 6a and c](#fig6){ref-type="fig"}). In accordance with our previous experiments, endothelial damage appeared to even be amplified when free huHb was added to the H~2~O~2~-generating system and, consequently, toxic denaturation products were formed ([Figure 6c](#fig6){ref-type="fig"}). However, the gene expression analysis shown in [Figure 6b](#fig6){ref-type="fig"} suggested that Hb switches the cellular mechanism of H~2~O~2~-mediated damage from oxidative stress to inflammation. In agreement with the H~2~O~2~-consuming activity of Hb, the H~2~O~2~-associated gene cluster (gene cluster A) was normalized when extracellular Hb was present in the treatment. The top upregulated gene within this H~2~O~2~ signature cluster is the stress-signaling transcription factor ATF3 ([Supplementary Excel file](#sup1){ref-type="supplementary-material"}).^[@bib27]^ In contrast, the new gene cluster that appeared when Hb was added to the oxidative system represents inflammation (gene cluster B). The Hb-mediated switch from oxidative stress to inflammation could be confirmed by quantitative real-time polymerase chain reaction (RT-PCR) as a clear switch of high ATF-3 → high SELE gene expression ([Figure 6d](#fig6){ref-type="fig"}).

[Supplementary Figure 3](#sup1){ref-type="supplementary-material"} illustrates the validation of our array gene expression data with TaqMan real-time PCR for 15 genes that represent the oxidative stress (a) and inflammatory (b) gene clusters shown in [Figures 6b](#fig6){ref-type="fig"}. For all genes, we found congruent expression patterns between gene array and PCR analysis, with a strong overall correlation between the two methods (Pearson *r*^2^=0.85; *P*\<0.0001).

The shielded Hb/Hp complex prevented both pathways of endothelial damage and attenuated all associated gene expression changes.

Discussion
==========

In a standardized cell culture model of concurrent Hb exposure and oxidative stress, we defined Hp-attenuated mechanisms by which Hb oxidation could damage the endothelium. Two primary mechanisms could be defined ([Figure 7](#fig7){ref-type="fig"}). The first mechanism involves Hb denaturation products that trigger a strong inflammatory response, whereas the second mechanism involves a cytotoxic reaction induced by oxidatively transformed bystander molecules (i.e., LDL). Hp stabilizes the Hb structure (preventing mechanism 1) and shields the environment from Hb-catalyzed oxidation (preventing mechanism 2). These unique protective functions of Hp indicate an unrecognized biological role of the Hb/Hp complex. Within the complex, the pseudoperoxidase activity of Hb is switched from a destructive to a protective reaction, which may ultimately help to preserve cell integrity during peroxidative stress.

Our *in vitro* model is conceptually based on a correlative analysis of (1) diverse cellular responses upon *in situ* oxidative reactions of different types of Hb and (2) common and divergent structure and reaction properties of these types of Hb in addition to the Hb/Hp complex.

When endothelial cells were exposed to human Hb in the presence of a nontoxic concentration of GOX, we observed a decrease in transendothelial resistance, a loss of adherens junction organization, and subsequently, a robust inflammatory response. This response was observed in experiments with several endothelial cell types and was completely prevented by the presence of Hp. In contrast to the experiments with human Hb, inflammatory responses, and cell damage were not observed when endothelial cells were exposed to the same peroxidative conditions in the presence of structure-stable Hbs. These results lead to the following questions: (1) What are the differences between the 'toxic\' and 'nontoxic\' types of Hb that could explain such a divergent biologic response? (2) Could this observation explain a mechanism whereby Hp could act as a protective Hb-binding protein?

The types of Hb in this study are very similar. Human Hb and *α*XLHb have the exact same peptide sequence and comparable quaternary structures and differ only in a defined chemical cross-linker that provides enhanced structural stability to *α*XLHb.^[@bib10]^ BvHb is a dissociable tetramer with enhanced protein stability to pro-oxidants because of differences in the amino-acid sequence that have accumulated during evolution. Our biochemical characterization confirmed that all three types of Hb are heme oxidized at comparable rates by H~2~O~2~, thus excluding the ferric (Fe^3+^) and ferryl (Fe^4+^) forms of Hb as the immediate cytotoxic species. Also, DEPMPO-trappable radicals were generated at comparable rates and are therefore unlikely to be a direct mediator of toxicity. We could also disqualify dissociated free heme as the ultimate mediator of cellular damage in this system as it is released from all types of Hb in the absence of Hp. Presumably, free heme did not exceed the threshold for toxicity in our model. In addition, the endothelial cells were likely protected from heme-mediated cytotoxicity by the presence of plasma proteins in the cell culture medium as well as by a strong baseline heme oxygenase 1 (HO-1) expression that was further enhanced during oxidative Hb stress. Rather, the role of free heme in our model concerns its ability to enhance oxidative modification of bystander molecules (if present).^[@bib1],\ [@bib29]^ In a previously published study, we also demonstrated that similar patterns and quantities of primary globin amino-acid oxidation end-products (i.e., formation of cysteic acid at position *β*Cys93) occurred during oxidation of native human and *α*XLHb.^[@bib30]^

Collectively, we can exclude the primary heme-oxidized Hb species (ferric Hb^3+^ or ferryl Hb^4+^), free heme, Hb oxidation-derived free radicals, and secondary globin amino oxidation products as being the immediate pro-inflammatory and cytotoxic compounds that emerge during Hb peroxidation.

Hb is prone to complex oxidation-driven structural modifications, such as loss of *α-*helical structure, covalent globin cross-linking, polymerization, and aggregation.^[@bib24],\ [@bib25]^ These Hb polymers/aggregates were the only reaction products that we found to occur with the toxic native human Hb but not with the two structure-stable Hbs. Endothelial cells extensively interacted with and internalized these degradation products before intercellular gaps, inflammation, and overt cellular damage could be observed. Therefore, as all the other considered reaction intermediates were the same among the three types of Hb, it is likely that these Hb degradation products triggered the adverse endothelial response. A similar process may also explain the toxicity of Hb that was oxidatively damaged by the bolus addition of H~2~O~2,~ as reported by the Soares group.^[@bib31]^ In our earlier work, we demonstrated biochemical evidence that Hp can stabilize the protein structure of Hb and that this stabilization is essential for the effective recognition of the complex by the macrophage Hb scavenger receptor CD163.^[@bib23]^ The model presented in this paper allows us to now, for the first time, relate this Hb-stabilizing activity of Hp to a strong anti-oxidative protective function within a biological system.

In an extended model that contained extrinsic reactive molecules that could be modified by Hb\'s peroxidative reactivity, we could confirm that Hb-catalyzed oxidative reactions also generate toxic non-globin products. In this model, the external 'mediator molecule\' (LDL) bears the primary impact of the free radical reactivity and is thereby transformed into a toxic compound (i.e., oxLDL). This mechanism of Hb toxicity is independent of globin stability and is in agreement with numerous earlier studies that explored the lipid-peroxidative properties of free heme and Hb, particularly in the context of atherosclerosis.^[@bib29],\ [@bib32],\ [@bib33]^ The discriminating gene expression responses triggered by the Hb degradation and LDL peroxidation products, respectively, suggest that not only the extracellular reactions and toxic species but also the cellular signaling pathways clearly differ between these two principal mechanisms of Hb toxicity.

Hp was also capable of blocking Hb-driven LDL oxidation and thereby being protective against this second ('extrinsic\') mechanism of Hb-driven endothelial damage. Therefore, the cumulative protective activity of Hp is related to Hp\'s ability to stabilize the globin structure and to 'shield\' transition of oxidation equivalents from Hb to other molecules.^[@bib11],\ [@bib33]^

In the absence of strong protective mechanisms, such as Hp, oxidative side reactions of extracellular Hb could ultimately link tissue destruction, bleeding, local hemolysis, and oxidative stress to accelerated inflammation and tissue damage. Our studies provide now the first experimental evidence that Hp can act as a molecular switch, which alters the peroxidative reaction of Hb away from pro-inflammatory and cytotoxic toward a protective function.

Materials and Methods
=====================

Endothelial cell culture models
-------------------------------

All primary human endothelial cells and the respective cell culture media were from Lonza (Basel, Switzerland). Cells were cultured for a maximum of six passages. The following types of Hb were used throughout the studies: (1) stroma-free human Hb (HbA0, huHb), which was catalase depleted by DAEA chromatography. (2) Catalase-free ultrapure bvHb. (3) DBBF*α*XLHb, both of which were provided by Dr. Abdu Alayash, FDA. Hb/H~2~O~2~ experiments were performed with either 2.5 mU/ml (low GOX activity) or 20 mU/ml GOX (high GOX activity; from Sigma Chemical Co., St. Louis, MO, USA) as indicated. Hb was used at 2 mg/ml (ferrous Hb) and glucose was used at 4 g/l. All experiments were performed in complete culture medium (i.e., containing 2% fetal calf serum and without phenol red). Electrical resistance of the endothelial cell monolayers was measured in real time with an electric cell--substrate impedance sensing (ECIS) Z Theta instrument (ibidi GmbH, Planegg/Martinsried, Germany) that used eight-well disposable electrode arrays (8W10+). ECIS software version 1.2.52 was used to operate the instrument and for the subsequent data modeling and analysis.

Analysis of Hb oxidation and radical production during GOX reactions
--------------------------------------------------------------------

Spectral analysis of Hb oxidation by GOX-derived H~2~O~2~ was performed with a Cary 60 UV-VIS Spectrophotometer (Agilent Technologies, Basel, Switzerland). The reactions were monitored in complete endothelial cell culture medium under conditions identical to those of the cell culture itself (37 °C). Full spectra were recorded every 3 min and deconvoluted to calculate the concentrations of the different reaction species.^[@bib34]^ For the evaluation of aggregate formation, the reactions were continuously measured at 700 nm. For electron paramagnetic resonance (EPR) spin-trapping experiments, the same reactions were performed in the presence of the spin trap DEPMPO (10 mM). During the reaction, samples were measured sequentially in a Bruker ElexSys E500 \@9.6 GHz X-band cw spectrometer (Bruker BioSpin AG, Faellanden, Switzerand).

Hb-Hpx heme transfer
--------------------

MetHb (Fe^3+^) of the indicated Hbs was incubated (10 *μ*M in phosphate-buffered saline (PBS) pH 7.4) with a twofold molar excess of Hpx (from Athens Research and Technology, Inc., Athens, GA, USA). Serial UV-VIS spectra were recorded with a Cary 60 UV-VIS Spectrophotometer (Agilent Technologies) and deconvoluted to follow the transition of metHb to heme-Hpx spectra.

LDL peroxidation assay
----------------------

Human plasma-derived LDL was a kind gift of Dr. Lucia Rohrer, Institute of Clinical Chemistry, University Hospital of Zurich, Zurich, Switzerland. The oxidation of LDL (0.1 mg/ml in PBS, pH 7.4) was measured in a closed, stirred microrespiration system with a Clark-type oxygen electrode (Unisense, Aarhus, Denmark) at 37 °C after the injection of Hb in the Fe^3+^ form (final Hb concentration was 10 *μ*M heme).

Quantitative real-time RT-PCR
-----------------------------

RT-PCR has been performed as described.^[@bib35]^ Sequence-specific primers were as follows: HO-1 fwd 5′-AGGGTGATAGAAGAGGCCAAGACT-3′ and rev 5′-TTCCACCGGACAAAGTTCATGGC-3′ ATF3 fwd 5′-CAAGTGCATCTTTGCCTCAA-3′ and rev 5′-CCACCCGAGGTACAGACACT-3′, SELE fwd 5′-AGCCCAGAGCCTTCAGTGTA-3′ and rev 5′-AACTGGGATTTGCTGTGTCC-3′. Relative mRNA levels were calculated by the 7500 Fast System Sequence Detection Software Version 1.4 (Applied Biosystems, Rotkreuz, Switzerland) after normalization of each experimental sample to HPRT levels. The confirmation PCR experiments shown in [Supplementary Figure 3](#sup1){ref-type="supplementary-material"} were performed with predesigned TaqMan Gene Expression Assays (Life Technologies, Basel, Switzerland). Probe set information can be obtained from the suppliers webpage using the IDs provided in the table ([www.invitrogen.com](http://www.invitrogen.com)).

Gene expression microarray experiments and data analysis
--------------------------------------------------------

After washing and lysing the cells with buffer RLT, total RNA was isolated using the RNeasy Mini Kit according to the manufacturer\'s instructions, which included an on-column DNA digestion step (RNase-Free DNase Set, Qiagen Hombrechtikon, Switzerland). To ensure that only high-quality RNA (RNA integrity number\>7.0) was used for gene expression analysis, each RNA sample was checked on a RNA Nanochip with a Bioanalyzer 2100 (Agilent Technologies). RNA was quantified spectrophotometrically with a NanoDrop ND-1000 spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA). Fluorescently labeled cRNA was generated from 500 ng total RNA with the Quick Amp Labeling Kit (Agilent Technologies) according to the manufacturer\'s protocol, and differential gene expression profiling was performed by competitive dual-color hybridization on Whole Human Genome Oligo Microarrays (G4112F, 4 × 44 K, 60-mer, Agilent Technologies). Array slides were XDR scanned and analyzed with Feature Extraction Software Version 10.7.3.1 (Agilent Technologies). Statistical analysis and visualization was performed with JMP Genomics 5.0 (SAS Institute, Boeblingen, Germany). Full gene array data were submitted to gene expression omnibus (GEO Accession \#: GSE46471).

Confocal microscopy
-------------------

For confocal immunofluorescence microscopy, human endothelial cells were cultured on sterile, round 12-mm glass coverslips (Hecht-Assistent, Sondheim, Germany) coated with rat-tail collagen (BD Biosciences, San Jose, CA, USA) in 24-cluster wells. After treatment, cells were washed with PBS, pH 7.4 (Sigma Chemical Co.), before fixation with 2.5% paraformaldehyde in PBS for 15 min. Permeabilization was performed for 5 min with 0.1% Triton X-100 (Sigma Chemical Co.) in PBS at room temperature. After washing, nonspecific binding sites were blocked for 1 h at room temperature with 10% goat serum in PBS, supplemented with 1% bovine serum albumin (Sigma Chemical Co.). Staining for *β*-catenin was performed with a polyclonal rabbit antihuman *β*-catenin antibody (Cell Signaling Technology, Danvers, MA, USA) overnight at 4 °C at a dilution of 1 : 150 in PBS with 1% goat serum and 0.1% bovine serum albumin. A Cy3-labeled polyclonal sheep anti-rabbit antibody (IgG fraction; Abcam, Cambridge, UK) was used as a secondary antibody at a dilution of 1 : 50, and F-actin staining was performed with green fluorescently (Alexa Fluor 488 dye) labeled Phalloidin (Invitrogen, Basel, Switzerland) at a dilution of 1 : 80. Nuclear counterstaining was performed with 10 mcg/ml 4,6-diamidino-2-phenylindole (DAPI; Sigma Chemical Co.). After three washes in PBS, coverslips were mounted with ProLong Gold antifade reagent-mounting medium (Molecular Probes, Invitrogen, Eugene, OR, USA). Samples were analyzed as z-stacks with a Leica SP5 confocal laser-scanning microscopy system (Leica, Heidelberg, Germany) with a HXL PL APO lambda blue 63.0 × 1.40 OIL UV objective.

Correlative light-electron microscopy (CLEM) and SEM analysis
-------------------------------------------------------------

For CLEM analysis, endothelial cells were cultured as described above for confocal microscopy on square-cut indium-tin-oxide (ITO) -- coated 10 × 10 mm glass coverslips marked for the shuttle and find solution integrated in the AxioVision Software 4.8.2 (Carl Zeiss AG, Feldbach, Switzerland). Cells were fixed with 2.5% paraformaldehyde in PBS for 15 min and directly stained (i.e., without a permeabilization step) for *β*-catenin and F-actin as described for confocal microscopy. Cells were kept in PBS after staining and during all fluorescence light microscopy (FLM) imaging procedures with the coverslips placed in a sample holder especially designed for CLEM. Widefield FLM images were recorded with an Axio Imager M1 (Carl Zeiss AG) with a 20 × water emersion objective and an AxioCam MRm. The samples were then prepared for electron microscopy and transferred to a Zeiss Gemini 1530 FEG SEM (Gloor Instruments AG, Uster, Switzerland). With the shuttle and find module of the AxioVision Software (Carl Zeiss AG), regions of interest were relocated and SEM imaging was performed. Overlays of the FLM and SEM pictures were performed with Adobe Photoshop Software CS3 (Adobe Systems Incorporation, San Jose, CA, USA). In some specimens, SEM analysis was performed in more detail and independent of the correlative FLM images.

For SEM analysis, cell monolayers on ITO glass substrates were fixed in 2,5% glutharaldehyde (Sigma Aldrich, Sigma-Aldrich Chemie GmbH, Buchs, Switzerland) in PBS, washed in PBS, postfixed in 1% OsO~4~ (Electron Microscopy Sciences, Hatfield, PA, USA), washed, incubated in 1% carbohydrazide (Sigma Aldrich) in distilled water, washed, stained again in 1% OsO4, and washed. After dehydration in a graded series of ethanol, the cell monolayers were plunged into liquid nitrogen and freeze dried at −120 °C up to −80 °C overnight (in a freeze etching system BAF060 from BalTEC AG, Balzers, Liechtenstein). Dried samples were warmed up to room temperature, mounted to stubs with conductive carbon cement (Leit-C, Neubauer Chemikalien, Munster, Germany), and sputter coated with 5 nm platinum (BalTEC sputter coater: MED 010). Microscopy was performed in a Zeiss Gemini 1530 FEG in secondary electron mode at 5 kV.

For dual-beam microscopy (focused ion beam-SEM FIB/SEM), the cell monolayers were treated as described for SEM but were soaked with Epon/Araldite resin (compounds from Fluka analytical (Buchs, Switzerland) and Sigma live sciences (Buchs, Switzerland)) after the dehydration. The resin was polymerized for 2 days at 60 °C, samples were trimmed and mounted and sputter coated as mentioned above. Cross-sections were performed in a Zeiss NVision 40 dual-beam microscope with gallium beam at 30 kV and 1.5 nA. Imaging of consecutive sections were performed using back scatter electron signal at 2 kV with an isotrope voxel size of 20 nm. Images were aligned in Fiji/ImageJ (<http://fiji.sc>) and visualized in Imaris (Bitplain AG, Zurich, Switzerland).
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![Hb oxidation, endothelial damage, and Hp protection. (**a**) Endothelial monolayer electrical resistance during treatment with human Hb (huHb, 2 mg/ml), a low/nontoxic level of GOX (2.5 mU/ml), or the combination of huHb+GOX. Only the combination of huHb+GOX resulted in a significant decline of endothelial resistance over time. ECIS traces represent means±S.D. of four replicate measurements. (**b**) The decline of HPAEC monolayer resistance was morphologically associated with a redistribution of the adherens junction protein *β*-catenin (red) in fluorescence light microscopy (blue=DAPI-stained nuclei). Imaging of the same specimen region with a correlative SEM revealed intercellular gap formation (arrow head) with intercellular space spanning filopodia in the regions with decreased *β*-catenin staining. The arrow indicates a conglomerate of Hb aggregates. No changes were observed when cells were only treated with Hb or GOX alone (data not shown). The incubation time in these experiments was 6 h. (**c**) *β*-Catenin (red) redistribution in HPAECs was completely prevented when Hp (2 mg/ml) was present during the combined huHb+GOX treatment in confocal laser scanning microscopy images (original magnification × 630)](cdd2013113f1){#fig1}

![Hb oxidative stability, aggregate formation, and endothelial damage. (**a**) Aggregate formation during the reaction of H~2~O~2~ (GOX 2.5 mU/ml) with the different types of Hb (2 mg/ml) was recorded by time-resolved spectrophotometry at 700 nm under identical conditions as in the ECIS experiment with HPAEC shown in (**b**). At equal H~2~O~2~ exposure, endothelial barrier function was compromised in the presence of huHb but not in the presence of the structure-stable *α*XLHb or bvHb. The addition of Hp (2 mg/ml) to the huHb+GOX reaction (red line) completely prevented aggregate formation and endothelial barrier breakdown (blue line). (**c**) The aggregates/precipitates can be localized on HPAEC by SEM (images were recorded after 5 h). No aggregates can be visualized in the presence of Hp. (**d**) Internalization of the Hb aggregates (arrows) by the endothelial cells can be observed on zoom-in cell surface views (insert) and in a 3D reconstruction of serial sections recorded with a FIB-SEM instrument. The white color appearance of the Hb precipitates on the front section of the 3D image is indicative of the high density of these particles that allowed automatic recognition and reconstruction by the image processing software (Imaris Software), which clearly show internalized particles as well as particle aggregates on the surface of the cell](cdd2013113f2){#fig2}

![Biochemical characterization of the H~2~O~2~ reactions with human Hb, bvHb, *α*-*α-*cross-linked Hb, and the Hb/Hp complex. (**a**) Time-resolved analysis of the reactions of the different types of Hb in complete endothelial cell culture medium at 37 °C. Spectra were recorded at 2-min intervals and deconvoluted to calculate the concentrations of the individual Hb oxidation states. (**b**) Heme release and transfer to Hpx from ferric Hb. Serial spectra were recorded from a mixture of ferric Hb (12.5 *μ*M) with a 10-fold molar excess of Hpx. The first spectrum is red (ferric Hb) and the last recorded spectrum is blue (heme-Hpx). The insert shows the reference spectra of ferric Hb (red) and heme-Hpx (blue), respectively. (**c**) Decay of ferric Hb over time. (**d**) Radical generation during Hb-H~2~O~2~ reactions was explored with spin-trapping EPR under the same conditions used for endothelial cell culture (cell culture medium, Hb (2 mg/ml), and GOX (2.5 mU/ml)) in the presence of 50 mM DEPMPO. EPR spectra (left panel) of the different experimental samples were recorded sequentially over time, and the integrated spectral values are plotted in the right panel. The insert shows an anti-DMPO Western blot of Hbs reacted with H2O2 in the presence of DMPO. The signals indicate generation of protein based radicals](cdd2013113f3){#fig3}

![Intrinsic and extrinsic reaction pathways of Hb peroxidative endothelial damage. (**a**) The 'intrinsic\' oxidation pathway (red) involves globin oxidation with the subsequent formation of Hb aggregates that induce direct endothelial damage. The proposed 'extrinsic\' pathway (violet) involves oxidative transformation of bystander molecules (i.e., LDL) into toxic reaction products. (**b**) HUVECs and HPAECs were incubated with either LDL (0.5 mg/ml)+GOX 2.5 mU/ml, bvHb (2 mg/ml)+GOX, or LDL +bvHb+GOX to explore the extrinsic pathway of peroxidative toxicity. To compare the extrinsic pathway with the intrinsic pathway, some cells were treated with huHb (2 mg/ml)+GOX. Transendothelial resistance was measured with an ECIS instrument. (**c**) Hb-mediated LDL oxidation and protection by Hp. Left panel: O~2~ consumption was measured with an O~2~ sensitive micro-electrode in stirred reaction mixtures of LDL with huHb-Fe^3+^ (red), *α*XLHb-Fe^3+^ (dark violet), bvHb-Fe^3+^ (black), or huHb-Fe^3+^/Hp complex (blue). Right panel: the Hb/Hp complex (blue line) delayed the breakdown of endothelial electrical resistance compared with when *α*XLHb (dark violet) or bvHb (violet) were used in the reaction mixture with LDL+GOX. The control treatment (black line) was LDL+GOX in the absence of any Hb (LDL 0.5 mg/ml and Hbs 0.1 mg/ml). All ECIS traces represent mean±S.D. values of four replicate measurements](cdd2013113f4){#fig4}

![Gene expression analysis of endothelial cells exposed to Hb-catalyzed oxidative reactions. (**a**) Reaction components (= endothelial cell treatments) and the proposed *in situ* reaction intermediates and end products. (**b**) HPAECs were exposed to the indicated components for 8 h. The global mRNA expression pattern was analyzed by Agilent gene expression arrays. In the PCA, the global expression profile of each sample is represented as a ball that is color coded for its treatment condition. (**c**) Hierarchical clustering analysis of all genes that were significantly changed from baseline expression by any treatment condition. Each column represents the color-coded gene expression pattern of a single sample. Treatment conditions are indicated at the top of the graph. The treatment discriminative gene clusters that were used for functional network analysis are indicated at the right border of the graph. (**d**) The treatment discriminative gene clusters A (LDL peroxidation) and B (Hb degradation) were analyzed with Metacore software for the enrichment of functional gene networks. The 10 most significantly enriched networks are indicated](cdd2013113f5){#fig5}

![The Hb/Hp complex is a protective sink for cytotoxic extracellular H~2~O~2~. High-dose H~2~O~2~-mediated endothelial cell toxicity was mimicked by treating confluent HUVEC endothelial monolayers with 20 mU/ml GOX (high GOX). (**a**) *β*-Catenin (red) immunofluorescence of endothelial cells incubated with high GOX, high GOX+huHb, or high GOX+Hb/Hp (blue=DAPI-stained nuclei, original magnification × 630). (**b**) Global gene expression changes observed after 8 h with the treatments indicated on the top of the graph. The heat-map shows the result of a hierarchical clustering of the most significantly upregulated (red) and downregulated (blue) genes (compared with untreated controls). While there appeared to be almost no significant gene expression changes after high GOX+Hb/Hp treatment, distinct and mutually exclusive clusters of highly regulated genes appeared after treatment with either high GOX alone (→ oxidative stress) or high GOX+huHb (→ inflammation). (**c**) The breakdown of electrical resistance observed during high GOX treatment (red line) was exaggerated when huHb (2 mg/ml) was added to the system (blue line) and completely halted by the addition of Hb/Hp (2 mg/ml) (grey line). (**d**) RT-PCR confirmation of the representative signature genes of the oxidative stress response (*ATF3*), which was induced by high GOX alone, and inflammation (*SELE*), which was only induced by high GOX+Hb. Hp attenuates both responses to control levels (date are presented as mean±S.D. of three independent experiments)](cdd2013113f6){#fig6}

![Schematic summary of Hb-catalyzed oxidative endothelial damage and protection by Hp. Graphical illustration of the principal Hb toxicity and Hp protection pathways described in this study. We propose that Hp protects against peroxidative Hb toxicity by stabilizing the Hb structure (mechanism 1) and by shielding extrinsic molecules against Hb/heme-mediated peroxidative damage (mechanism 2)](cdd2013113f7){#fig7}
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